Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PCSK9 inhibitors
PCSK9 inhibitors
Amgen cholesterol drug succeeds in late-stage trial
Yahoo/Reuters
Thu, 12/19/13 - 11:13 am
Amgen
cholesterol
evolocumab
PCSK9 inhibitors
The Growing Need For Outcome Studies And The Impact On R&D Costs
Forbes
Mon, 12/2/13 - 09:42 am
clinical outcomes
R&D
PCSK9 inhibitors
Slouching Toward Phase 3: Progress Report On New Cholesterol Drugs At The AHA
Forbes
Mon, 11/25/13 - 09:12 am
cholesterol
PCSK9 inhibitors
evolocumab
Amgen
Data on Amgen's Pipeline Candidates
Yahoo/Zacks.com
Thu, 11/21/13 - 11:05 am
Amgen
evolocumab
PCSK9 inhibitors
cholesterol
Talimogene Laherparepvec
Amgen cholesterol drug appears safe, cut LDL 52 pct at 1 year-study
Yahoo/Reuters
Wed, 11/20/13 - 08:31 am
Amgen
cholesterol
asevolocumab
PCSK9 inhibitors
A Shifting Paradigm in Heart Disease Could Affect These Drugmakers
Motley Fool
Mon, 11/18/13 - 10:01 am
heart disease
Amgen
statins
Regeneron
Pfizer
Sanofi
PCSK9 inhibitors
FDA says new cholesterol drugs may not need outcome studies
Yahoo/Reuters
Fri, 11/15/13 - 08:37 am
FDA
cholesterol
PCSK9 inhibitors
statins
Pfizer
Amgen
Sanofi
Regeneron
U.S. heart guidelines may threaten hot new cholesterol drugs
Yahoo/Reuters
Wed, 11/13/13 - 12:47 pm
cholesterol
statins
PCSK9 inhibitors
Sanofi
Regeneron
Pfizer
Amgen
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Forbes
Fri, 11/1/13 - 08:28 am
Pfizer
PCSK9 inhibitors
RN-316
Sanofi
Regeneron
REGN727
AMG145
Amgen
New Type of Drug to Lower LDL Looks Promising
Med Page Today
Thu, 10/3/13 - 11:33 am
LDL cholesterol
Alnylam
PCSK9 inhibitors
Sanofi cholesterol drug touted as potential $3 billion blockbuster
Reuters
Thu, 09/26/13 - 10:25 am
Sanofi
Regeneron
alirocumab
PCSK9 inhibitors
Regeneron's CEO Talks About His Drugs For Eye Disease, Cholesterol, And Asthma Comment Now Follow Comments
Forbes
Thu, 08/15/13 - 11:57 am
Regeneron
Pharma CEOs
Eylea
Leonard Schleifer
PCSK9 inhibitors
3 Potential Game Changers for America's No. 1 Killer
Motley Fool
Wed, 04/17/13 - 04:36 pm
heart disease
Novartis
serelaxin
Pfizer
Inspra
Regeneron
Sanofi
PCSK9 inhibitors
Statins Beware?
Motley Fool
Mon, 01/28/13 - 12:21 pm
statins
PCSK9 inhibitors
Sanofi
Amgen
Pfizer
Roche
Regeneron
Better Than Lipitor! Higher Sales?
Motley Fool
Tue, 01/1/13 - 11:53 am
Pfizer
Lipitor
Juxtapid
Aegerion
Kynamro
Sanofi
Isis Pharmaceuticals
Regeneron
Alnylam
PCSK9 inhibitors
New Drugs for Lipids Set Off Race
NY Times, NY
Tue, 11/6/12 - 12:07 pm
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
Pfizer
Roche
Pages
« first
‹ previous
1
2
3
4
5
6
7
8